GSK's consumer health spinout Haleon started trading on the London Stock Exchange this morning, making its debut with a price of 330 pence and a market valuation of around £31 billion ($37 billion).

Sign Up for Wine Spectator’s Free Email Newsletters and stay up-to-date with all things wine.